Professional Documents
Culture Documents
Desain Penelitian Overview - Dr. Kuntjoro Harimukti, SPPD (K)
Desain Penelitian Overview - Dr. Kuntjoro Harimukti, SPPD (K)
An Overview
Kuntjoro Harimurti
Department of Internal Medicine Center for Clinical Epidemiology and EBM (CE-EBM) Cipto Mangunkusumo Hospital / Faculty of Medicine UI, Jakarta
kuntjoro.harimurti01@ui.ac.id
Research Design
A specific plan or protocol for conducting the study, which allows the investigator to translate the conceptual hypothesis into an operational one All procedures for selecting and recruiting individuals in the study sample
Experimental Studies
Uncontrolled Controlled
Observational Studies
A study in which the investigator monitors, but does not influence, the exposure status of individual subjects and their subsequent disease status
Cross-sectional study
A study in which determinant (risk factors) and outcome (disease) are collected at the same point in time for each participant Characteristics of cross-sectional study:
Observational = non-experimental
No time-axis Individual observed only once Could be descriptive or analytic
Etiologic studies
Determinant characteristics that do not change (sex, gene expression) Estimate probability of disease presence on basis of diagnostic determinants
Diagnostic studies
Reference range studies Repeated cross-sectional studies
Measure change / evaluate intervention
Numerical variables
Mean Means difference Correlation coefficient
Case-control study
I would trust only six people in the world to do a proper case-control study (David L. Sackett) A study in which outcomes (disease/cases and no-disease/controls) identified first and risk factors accounted in and compared between cases and controls Characteristics of case-control study:
Observational Retrospective Analytic
Cohort study
Cohort: the tenth division of the Roman army. Cohort of war fighters In research: a cohort is a group of subjects from which data are collected
Cohort studies: disease-free subjects selected first according to the risk factor and further followed for the disease Prospective and restrospective cohort
Observational Designs
Case-control
E(-) Controls
E(-)
E(+)
E(+)
Cases
Controls
Retrospective Cohort
E(+)
E(-)
E(+)
E(-)
Cross-sectional Time
Exposure
Cases
Time
Cost Loss to follow up Estimating risk / RR Bias Cause-effect relationship
+ + + +
+ ++ +++ ++
+ + +++ ++ +++
++
+++ ++ +++ + +++
Experimental Study
A study in which the investigator influences the exposure status of individual subjects and then monitors the subjects outcome
Controlled
Not controlled
Randomised
Not randomised
Blinded
Not blinded
Clinical Trial
A randomized double-blind controlled clinical trial (RCT) Gold standard of research design which provide the most convincing evidence of relationship between exposure (intervention) and outcome Use human subject Always prospective Comparing two or more intervention strategies
Clinical Trial
Key elements of RCT:
Randomization Blinding Control
Objective: To achieve comparabilities
Comparabilities in RCT:
Comparability of prognostic factors Comparability of extraneous factors Comparability of outcome measures
R
Control Treatment
Time
Screening Baseline Treatment Outcome measurement
Analysis in RCT
Numerical outcome:
Means or medians difference after intervention (Student -t test or Mann-Whittney test) Per-protocol analysis
Categorical outcome:
Relative risk (RR), hazard ratio (HR) Relative and absolute risk reduction (RRR, ARR) Number needed to treat (NNT Intention-to-treat analysis
META-ANALYSIS
Meta-Analysis
Quantitative method of combining the results of independent research (primary) studies and synthesizing conclusions to evaluate the effectiveness of treatments or procedures Begins with systematic finding, evaluating, and presenting the results of primary studies Systematic Review No collecting data directly from the study subjects secondary research Considered as true investigation and has highest rank in level-of-evidence
Advantages of Meta-analysis
Quantitatively summarize estimate from previous studies resolve controversies Using protocol to choose the individual studies avoid bias
Increase power for statistical test and increase precision for confidence intervals
Conclusions often reflect broad spectrum of patient and characteristics results are more generalizable
Heterogeneity
Combining combinable studies
Publication bias
Unpublished negative and small studies
0.1
Favor drug
OR = 1
10
Favor placebo
-1.0
+1.0
Clinical Research
Clinical research involves working with human subjects to answer questions relevant to their well-being Clinical (epidemiology) research addresses questions regarding clinical practice challenges Patient oriented research is where the rubber meets the road!
Diagnostic research
Aim: to predict the probability of presence of target disease from clinical and non-clinical profile Relevance for patient and physician to establish diagnosis and guide management Results presentation: sensitivity, specificity, positive and negative predictive values, likelihood ratios, scoring system Example: Wells clinical prediction rule for DVT and PE
Etiologic research
Aim: to causally explain ocurrence of target disaese from determinant (risk factor) Research relevance may indicate means of prevention and causal intervention
Results presentation: odds ratio (OR), relative risk (RR), hazard ratio (HR)
Example: smoking and lung cancer study by Sir Bradford Hills
Prognostic Research
Aim: to predict of disease from clinical and non-clinical profiles Relevance for patient and physician to learn about future and guide management
Therapy/Interventional research
Aims: To casually explain and to predict the course of disease as influence by treatment Relevance for patient and physician to decide an optimal management and for drug research/development/registration Results presentation: absolute/relative risk reduction (ARR/RRR), number needed to treat (NNT)
Thank you...